VAZIGOC, CAPSER, AND TAVULOP SEMINAR AT TAY NGUYEN UNIVERSITY HOSPITAL

On August 7, 2026, Medbolide Pharma JSC co-hosted a scientific seminar at TAY NGUYEN University Hospital. The event was attended by doctors, pharmacists, and healthcare professionals currently working at the hospital.

At the seminar, representatives from Medbolide Pharma JSC presented updated information, clinical data, and the key benefits of Vazigoc (Thiabendazole 500 mg), Capser (Capsaicin 0.075%), Tavulop (Olopatadine 0,2%) products, with the aim of providing additional effective and optimal treatment options for clinical practice.

Following the presentation, the attending doctors and pharmacists engaged in lively discussions, exchanged professional insights, and expressed interest in the treatment solutions offered by Medbolide.

At the conclusion of the presentation, a representative from Medbolide Pharma JSC extended sincere thanks to CEO and all doctors and medical staff at TAY NGUYEN University Hospital, while also expressing a desire to continue a long-term partnership with the hospital in its mission to care for and improve the health of patients.